Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced an expansion of its registrational program with the addition of Brooks Rehabilitation Hospital. This strategic alliance is expected to …
Helius Medical Technologies Expands Stroke Program, Investors Eye Potential Returns Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …
Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) this week outlined its business outlook for 2024, highlighting upcoming clinical milestones and a robust financial position that could make it an …
Arbutus Biopharma: Promising Clinical Trials and Patent Litigation Could Drive Investor Interest in 2024 Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has announced the first patient was randomized in its BACKBEAT pivotal study in late December 2023. This marks a significant …
Orchestra BioMed’s Bioelectronic Therapy Pivotal Study Begins: A Potential Game-Changer for Hypertensive Patients Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced a clinical collaboration and supply agreement with Coherus BioSciences, Inc. (NASDAQ: CHRS) to evaluate the combination of INO-3112 and LOQTORZI™ (toripalimab-tpzi) …
INOVIO and Coherus BioSciences Join Forces for Phase 3 Clinical Trial in Throat Cancer Treatment Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leader in dermatology therapeutics, announced a significant development in its ongoing research for innovative skin cancer treatments. The company confirmed …
Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that it received the minutes from its recent Type C meeting with the U.S. Food and Drug Administration (FDA). …
Verrica Pharmaceuticals Gains FDA Alignment for YCANTH’s Phase 3 Clinical Development Plan Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a Pennsylvania-based biotechnology company, has announced new preclinical data on two of its drug candidates, istaroxime and CVie-216. The drugs have shown …
Windtree’s Innovative Drugs Show Promising Reductions in Ventricular Arrhythmias Read More